INXC-6295: Began Phase I/II testing

Inex Pharmaceuticals Corp. (TSE:IEX), Vancouver, B.C. Product: INXC-6295 Business: Cancer Therapeutic category: Antisense Target: C-myc RNA Description: Transmembrane Carrier System encapsulated anti...